AI project to power the future of Stem Cell Manufacturing

Deep stain cell image

Press Release: Today ValitaCell announces a collaboration with CeADAR on a ground breaking, Artificial Intelligence project called Deepstain

A new project to improve stem cell manufacturing using Artificial Intelligence (AI) could have lasting impacts for the health sector.

A three-year project, entitled ‘DeepStain: Deep Learning for Cell Image Analysis’ hopes to accelerate an area of drug development which is at the root of many diseases.

DeepStain is part of a strategic partnership between ValitaCell, an award winning Irish biotechnology company and CeADAR, Ireland’s Centre for Applied Artificial Intelligence.

The project has received €242,000 funding from Enterprise Ireland and the EU under the Marie Skłodowska-Curie Co-Fund Scheme, which is part of the large Horizon 2020 Research and Innovation programme.

This innovative programme matches top talent and skills coming from all around the world with the research needs of enterprises in Ireland.

Stem cells have the potential to treat many conditions, including cancer, arthritis, and Crohn’s disease, yet they can be hard to manufacture. This is because monitoring stem cell quality involves a lot of slow and difficult laboratory work. 

The DeepStain project will use Artificial Intelligence to quickly analyse images of stem cells to determine their quality and make stem cell manufacturing more efficient. 

The core team is composed of Dr. Ricardo Simon Carbajo (CeADAR), Dr. Paul Dobson (ValitaCell) and Dr. Polat Göktaş(CeADAR & ValitaCell), and builds on previous work and interdisciplinary expertise.

Dr. Ricardo Simon Carbajo, Head of Innovation & Development at CeADAR said:

AI can massively help to improve the Biopharma value chain. In this project, we will be applying the latest techniques in Computer Vision to speed up the process of manufacturing stem cells. We are delighted to partner with ValitaCell as they are truly innovating in this area and we can produce a real impact in society” 

Dr. Paul Dobson, Head of Data at ValitaCell said:

Working with CeADAR will help ValitaCell leverage the power of Deep Learning to create better bioprocess analytical technologies to support stem cell therapy manufacturing. This will help translate stem cells from being a niche experimental therapy into a treatment available to patients worldwide.”

Dr. Paul Dobson
Dr. Paul Dobson
Head of Data

Dr. Paul Dobson is an expert in Artificial Intelligence and Deep Learning and is ValitaCell's Head of Data. Paul leads the Deepstain project for Valitacell.

Dr. Ricardo Simon Carbajo
Head of Innovation & Development | CeADAR

Dr Ricardo Simon Carbajo is the Head of Innovation & Development at CeADAR. Ricardo leads the IDG group, composed of senior data scientists, which focuses on the development of bespoke advanced data analytics and AI solutions for SMEs and MNCs operating in a large range of verticals (energy, manufacturing, insurance, fintech, healthcare, telecoms, etc). He is also responsible for EU Research & Innovation.

Further Reading

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!